Content about Novopharm

August 15, 2012
Teva launches generic chemotherapy drug

A division of Teva Pharmaceutical Industries has launched a generic chemotherapy drug, the company said.

IRVINE, Calif. — A division of Teva Pharmaceutical Industries has launched a generic chemotherapy drug, the company said.

Teva Health Systems announced the introduction of oxaliplatin injection in the 50-mg and 100-mg strengths.

The drug is a generic version of Sanofi's Eloxatin, which had sales of $1.7 billion during the 12-month period ended in June, according to IMS Health.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

July 15, 2011
Teva completes acquisition of Japanese generics company

Teva Pharmaceutical Industries has completed its acquisition of Japan’s third-largest generics company, Teva said.

JERUSALEM — Teva Pharmaceutical Industries has completed its acquisition of Japan’s third-largest generics company, Teva said.

The Israeli drug maker, the world’s largest maker of generic drugs, announced that it had acquired effectively all the outstanding shares of Taiyo Pharmaceutical Industry Co. for $934 million.

August 9, 2010
Teva completes Ratiopharm acquisition

Israeli drug maker Teva Pharmaceutical Industries has finished its $5 billion acquisition of German generic...